Financial Snapshot: Analyzing Precigen Inc (PGEN)’s Key Ratio Metrics

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

The closing price of Precigen Inc (NASDAQ: PGEN) was $1.5 for the day, up 1.35% from the previous closing price of $1.48. In other words, the price has increased by $1.35% from its previous closing price. On the day, 1.68 million shares were traded. PGEN stock price reached its highest trading level at $1.55 during the session, while it also had its lowest trading level at $1.48.

Ratios:

Our analysis of PGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 3.53. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.29.

On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.

KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 442769984 and an Enterprise Value of 397463104. For the stock, the TTM Price-to-Sale (P/S) ratio is 105.42. Its current Enterprise Value per Revenue stands at 94.612 whereas that against EBITDA is -4.449.

Stock Price History:

The Beta on a monthly basis for PGEN is 1.78, which has changed by -0.032258093 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 4.55%, while the 200-Day Moving Average is calculated to be 20.45%.

Shares Statistics:

PGEN traded an average of 1.57M shares per day over the past three months and 1669180 shares per day over the past ten days. A total of 295.14M shares are outstanding, with a floating share count of 161.93M. Insiders hold about 45.14% of the company’s shares, while institutions hold 27.33% stake in the company. Shares short for PGEN as of 1748563200 were 27625665 with a Short Ratio of 17.63, compared to 1745971200 on 27703794. Therefore, it implies a Short% of Shares Outstanding of 27625665 and a Short% of Float of 16.239999.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.